<code id='D90381ECAA'></code><style id='D90381ECAA'></style>
    • <acronym id='D90381ECAA'></acronym>
      <center id='D90381ECAA'><center id='D90381ECAA'><tfoot id='D90381ECAA'></tfoot></center><abbr id='D90381ECAA'><dir id='D90381ECAA'><tfoot id='D90381ECAA'></tfoot><noframes id='D90381ECAA'>

    • <optgroup id='D90381ECAA'><strike id='D90381ECAA'><sup id='D90381ECAA'></sup></strike><code id='D90381ECAA'></code></optgroup>
        1. <b id='D90381ECAA'><label id='D90381ECAA'><select id='D90381ECAA'><dt id='D90381ECAA'><span id='D90381ECAA'></span></dt></select></label></b><u id='D90381ECAA'></u>
          <i id='D90381ECAA'><strike id='D90381ECAA'><tt id='D90381ECAA'><pre id='D90381ECAA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:255
          Sen. Elizabeth Warren gestures with one hand during a hearing — insurance coverage from STAT
          Sen. Elizabeth Warren (D-Mass.) Kent Nishimura/Getty Images

          Senate Democrats on Thursday said Medicare should take more urgent and aggressive action to prevent health insurance companies from using artificial intelligence to unlawfully deny medical services.

          The Biden administration’s latest efforts to increase transparency into AI tools don’t go far enough to protect patients, the lawmakers said at a Senate Finance Committee hearing.

          advertisement

          Sen. Elizabeth Warren (D-Mass.), citing a STAT investigation, took particularly sharp aim at the use of algorithms to deny care within Medicare Advantage. STAT’s stories had found repeated denials of desperately ill patients by the nation’s largest insurers.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Listen: More tumult at BIO & coercive care for sickle cell patients
          Listen: More tumult at BIO & coercive care for sickle cell patients

          Howdoesadrugindustrylobbyinggroupmoveforwardafteryearsofupheaval,includinghavingfourCEOsinfouryears?

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG